Noubar Afeyan insider trades: Moderna (MRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Noubar reports to the SEC
and 22 more companies
Open-market buys and sales
169 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | MRNA | ↓ Sell | 9,263 | $46.84 | $434K | By Flagship Pioneering, LLC | May 22, 2026 (1d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By Flagship Pioneering Fund VII, L.P. | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By FPN II, L.P. | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By Pioneering Medicines 02, LLC | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By Flagship Pioneering Fund VII, L.P. | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By Pioneering Medicines 02, LLC | Mar 2, 2026 (0d) |
| Mar 2, 2026 | GENB | ↑ Buy | 1,562,500 | $16.00 | $25.0M | By FPN II, L.P. | Mar 2, 2026 (0d) |
| Dec 11, 2025 | MRNA | ↓ Sell | 23,853 | $29.48 | $703K | By Flagship Pioneering, Inc. | Dec 15, 2025 (4d) |
| Jul 31, 2024 | MRNA | ↓ Sell | 15,000 | $119.96 | $1.8M | Direct | Aug 2, 2024 (2d) |
| Jul 24, 2024 | MRNA | ↓ Sell | 15,000 | $117.80 | $1.8M | Direct | Jul 26, 2024 (2d) |
| Jul 17, 2024 | MRNA | ↓ Sell | 15,000 | $122.84 | $1.8M | Direct | Jul 19, 2024 (2d) |
| Jul 10, 2024 | MRNA | ↓ Sell | 15,000 | $117.08 | $1.8M | Direct | Jul 12, 2024 (2d) |
| Jun 26, 2024 | MRNA | ↓ Sell | 15,000 | $127.22 | $1.9M | Direct | Jun 28, 2024 (2d) |
| Jun 18, 2024 | MRNA | ↓ Sell | 15,000 | $133.57 | $2.0M | Direct | Jun 21, 2024 (3d) |
| Jun 12, 2024 | MRNA | ↓ Sell | 15,000 | $147.20 | $2.2M | Direct | Jun 14, 2024 (2d) |
| Jun 11, 2024 | MRNA | ↓ Sell | 170,069 | $148.34 | $25.2M | By Flagship Ventures Fund IV, L.P. | Jun 11, 2024 (0d) |
| Jun 11, 2024 | MRNA | ↓ Sell | 32,763 | $148.34 | $4.9M | By Flagship Ventures Fund IV-Rx, L.P. | Jun 11, 2024 (0d) |
| Jun 5, 2024 | MRNA | ↓ Sell | 15,000 | $151.25 | $2.3M | Direct | Jun 7, 2024 (2d) |
| May 29, 2024 | MRNA | ↓ Sell | 20,000 | $145.08 | $2.9M | Direct | May 31, 2024 (2d) |
| May 22, 2024 | MRNA | ↓ Sell | 15,000 | $157.57 | $2.4M | Direct | May 24, 2024 (2d) |
| May 15, 2024 | MRNA | ↓ Sell | 15,000 | $127.32 | $1.9M | Direct | May 17, 2024 (2d) |
| May 8, 2024 | MRNA | ↓ Sell | 15,000 | $121.68 | $1.8M | Direct | May 10, 2024 (2d) |
| May 1, 2024 | MRNA | ↓ Sell | 15,000 | $110.92 | $1.7M | Direct | May 3, 2024 (2d) |
| Apr 24, 2024 | MRNA | ↓ Sell | 15,000 | $108.32 | $1.6M | Direct | Apr 26, 2024 (2d) |
| Apr 17, 2024 | MRNA | ↓ Sell | 15,000 | $103.38 | $1.6M | Direct | Apr 19, 2024 (2d) |
| Apr 10, 2024 | MRNA | ↓ Sell | 15,000 | $107.12 | $1.6M | Direct | Apr 12, 2024 (2d) |
| Apr 3, 2024 | MRNA | ↓ Sell | 15,000 | $101.68 | $1.5M | Direct | Apr 5, 2024 (2d) |
| Mar 27, 2024 | MRNA | ↓ Sell | 15,000 | $109.06 | $1.6M | Direct | Mar 29, 2024 (2d) |
| Mar 20, 2024 | MRNA | ↓ Sell | 15,000 | $102.39 | $1.5M | Direct | Mar 22, 2024 (2d) |
| Mar 13, 2024 | MRNA | ↓ Sell | 15,000 | $108.54 | $1.6M | Direct | Mar 15, 2024 (2d) |
| Nov 1, 2023 | MRNA | ↓ Sell | 10,000 | $76.00 | $760K | Direct | Nov 3, 2023 (2d) |
| Oct 25, 2023 | MRNA | ↓ Sell | 10,000 | $76.99 | $770K | Direct | Oct 27, 2023 (2d) |
| Oct 11, 2023 | MRNA | ↓ Sell | 15,000 | $103.30 | $1.5M | Direct | Oct 13, 2023 (2d) |
| Oct 4, 2023 | MRNA | ↓ Sell | 15,000 | $102.72 | $1.5M | Direct | Oct 6, 2023 (2d) |
| Sep 27, 2023 | MRNA | ↓ Sell | 10,000 | $98.96 | $990K | Direct | Sep 29, 2023 (2d) |
| Sep 20, 2023 | MRNA | ↓ Sell | 15,000 | $104.74 | $1.6M | Direct | Sep 22, 2023 (2d) |
| Sep 13, 2023 | MRNA | ↓ Sell | 15,000 | $109.70 | $1.6M | Direct | Sep 15, 2023 (2d) |
| Sep 6, 2023 | MRNA | ↓ Sell | 15,000 | $107.61 | $1.6M | Direct | Sep 8, 2023 (2d) |
| Aug 30, 2023 | MRNA | ↓ Sell | 15,000 | $115.46 | $1.7M | Direct | Sep 1, 2023 (2d) |
| Aug 23, 2023 | MRNA | ↓ Sell | 15,000 | $115.51 | $1.7M | Direct | Aug 25, 2023 (2d) |
| Aug 16, 2023 | MRNA | ↓ Sell | 10,000 | $97.56 | $976K | Direct | Aug 18, 2023 (2d) |
| Aug 2, 2023 | MRNA | ↓ Sell | 15,000 | $110.99 | $1.7M | Direct | Aug 4, 2023 (2d) |
| Jul 26, 2023 | MRNA | ↓ Sell | 15,000 | $120.42 | $1.8M | Direct | Jul 28, 2023 (2d) |
| Jul 19, 2023 | MRNA | ↓ Sell | 15,000 | $125.48 | $1.9M | Direct | Jul 21, 2023 (2d) |
| Jul 12, 2023 | MRNA | ↓ Sell | 15,000 | $125.81 | $1.9M | Direct | Jul 14, 2023 (2d) |
| Jul 11, 2023 | EVLO | ↑ Buy | 3,246,753 | $2.31 | $7.5M | By Flagship Pioneering Fund VII, L.P. | Jul 13, 2023 (2d) |
| Jul 11, 2023 | EVLO | ↑ Buy | 1,082,251 | $2.31 | $2.5M | By Nutritional Health LTP Fund, L.P. | Jul 13, 2023 (2d) |
| Jul 11, 2023 | EVLO | ↑ Buy | 1,082,251 | $2.31 | $2.5M | By Flagship Ventures Fund IV, L.P. | Jul 13, 2023 (2d) |
| Jul 5, 2023 | MRNA | ↓ Sell | 15,000 | $124.73 | $1.9M | Direct | Jul 7, 2023 (2d) |
| Jun 28, 2023 | MRNA | ↓ Sell | 15,000 | $121.54 | $1.8M | Direct | Jun 30, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MRNA insiders
Open-market trades in the last 12 months
About Noubar Afeyan's insider trades
Noubar Afeyan is an insider at Moderna (MRNA). Since Dec 14, 2006, Noubar has reported 57 open-market purchases worth $440.8M and 112 sales worth $1.77B on SEC Form 4. In the last 12 months: 6 buys ($150.0M) and 2 sales ($1.1M).
Their filings also include grants and awards (44 filings), conversions (30 filings), other transactions (27 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.